These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 8836613

  • 1. Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats.
    Polidori C, Ciccocioppo R, Pompei P, Cirillo R, Massi M.
    Eur J Pharmacol; 1996 Jul 04; 307(3):259-67. PubMed ID: 8836613
    [Abstract] [Full Text] [Related]

  • 2. The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats.
    Polidori C, Ciccocioppo R, Pompei P, Cirillo R, Massi M.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):223-8. PubMed ID: 7493612
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment.
    Polidori C, Ciccocioppo R, Nisato D, Cazaubon C, Massi M.
    Eur J Pharmacol; 1998 Jul 03; 352(1):15-21. PubMed ID: 9718262
    [Abstract] [Full Text] [Related]

  • 4. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
    Culman J, von Heyer C, Piepenburg B, Rascher W, Unger T.
    Eur J Pharmacol; 1999 Feb 19; 367(2-3):255-65. PubMed ID: 10079000
    [Abstract] [Full Text] [Related]

  • 5. Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.
    Fierens FL, Vanderheyden PM, De Backer JP, Vauquelin G.
    Eur J Pharmacol; 1999 May 14; 372(2):199-206. PubMed ID: 10395100
    [Abstract] [Full Text] [Related]

  • 6. Nonpeptide angiotensin II receptor antagonist: pharmacokinetics and pharmacodynamics in rats of EXP3174, an active metabolite of losartan.
    Wong PC, Christ DD, Wong YN, Lam GN.
    Pharmacology; 1996 Jan 14; 52(1):25-9. PubMed ID: 8966199
    [Abstract] [Full Text] [Related]

  • 7. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
    Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PB.
    J Pharmacol Exp Ther; 1990 Oct 14; 255(1):211-7. PubMed ID: 2213556
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of peptide and nonpeptide antagonists of angiotensin II receptors on noradrenaline release in hypothalamus of rats with angiotensin II-induced increase of water intake.
    Stancheva S, Alova L, Stefanova M.
    Pharmacol Rep; 2009 Oct 14; 61(6):1206-10. PubMed ID: 20081258
    [Abstract] [Full Text] [Related]

  • 10. Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors.
    Vanderheyden PM, Fierens FL, De Backer J, Vauquelin G.
    Biochem Pharmacol; 2000 Apr 15; 59(8):927-35. PubMed ID: 10692557
    [Abstract] [Full Text] [Related]

  • 11. Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist.
    Cirillo R, Renzetti AR, Cucchi P, Guelfi M, Salimbeni A, Caliari S, Castellucci A, Evangelista S, Subissi A, Giachetti A.
    Br J Pharmacol; 1995 Mar 15; 114(6):1117-24. PubMed ID: 7620700
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacological and pharmacokinetic evaluation of EXP3312, an orally-active non-peptide angiotensin II-receptor antagonist.
    Wong YN, Wong PC.
    J Pharm Pharmacol; 1996 May 15; 48(5):492-7. PubMed ID: 8799873
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans.
    Lo MW, Goldberg MR, McCrea JB, Lu H, Furtek CI, Bjornsson TD.
    Clin Pharmacol Ther; 1995 Dec 15; 58(6):641-9. PubMed ID: 8529329
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
    Inada Y, Wada T, Shibouta Y, Ojima M, Sanada T, Ohtsuki K, Itoh K, Kubo K, Kohara Y, Naka T.
    J Pharmacol Exp Ther; 1994 Mar 15; 268(3):1540-7. PubMed ID: 8138966
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists.
    Catalioto RM, Porchia R, Renzetti AR, Criscuoli M, Subissi A, Giachetti A.
    Eur J Pharmacol; 1995 Jul 14; 280(3):285-92. PubMed ID: 8566096
    [Abstract] [Full Text] [Related]

  • 18. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE, Cohen RB, Skwish S, Delaney CL, Serafino RP, Poss MA, Gu Z, Ryono DE, Moreland S, Powell JR.
    Br J Pharmacol; 1994 Sep 14; 113(1):179-89. PubMed ID: 7812609
    [Abstract] [Full Text] [Related]

  • 19. Binding of angiotensin antagonists to rat liver and brain membranes measured ex vivo.
    Marshall FH, Clark SA, Michel AD, Barnes JC.
    Br J Pharmacol; 1993 Jul 14; 109(3):760-4. PubMed ID: 8358571
    [Abstract] [Full Text] [Related]

  • 20. Dihydropyrimidine angiotensin II receptor antagonists.
    Atwal KS, Ahmed SZ, Bird JE, Delaney CL, Dickinson KE, Ferrara FN, Hedberg A, Miller AV, Moreland S, O'Reilly BC.
    J Med Chem; 1992 Dec 11; 35(25):4751-63. PubMed ID: 1469703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.